eculizumab 300 MG per 30 ML Injection
- RxCUI
- 700384
- RxNorm name
- eculizumab 300 MG per 30 ML Injection
- Display name
- eculizumab 300 MG per 30 ML Injection
- Full name
- eculizumab 300 MG per 30 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125166 | Soliris | eculizumab | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SOLIRIS | ECULIZUMAB | Alexion Pharmaceuticals Inc. | ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | 700384 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722 | eculizumab 300 MG in 30 ML Injection [PSN] · 30 ML eculizumab 10 MG/ML Injection [SCD] · eculizumab 300 MG per 30 ML Injection [SY] | 3 | 42 | These highlights do not include all the information needed to use SOLIRIS safely and effectively. See full prescribing information for SOLIRIS. SOLIRIS ® (eculizumab) injection, for intravenous use Initial U.S. Approval: 2007 | 20250307 |